State of New Jersey Common Pension Fund D’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Sell
511,409
-12,900
-2% -$430K 0.06% 266
2026
Q1
$15.8M Buy
524,309
+500
+0.1% +$16.1K 0.06% 261
2025
Q4
$16.3M Sell
523,809
-1,100
-0.2% -$27.1K 0.06% 247
2025
Q3
$10.6M Buy
524,909
+10,100
+2% +$177K 0.04% 348
2025
Q2
$8.63M Hold
514,809
0.03% 387
2025
Q1
$7.91M Buy
514,809
+41,300
+9% +$738K 0.04% 407
2024
Q4
$10.4M Hold
473,509
0.04% 360
2024
Q3
$8.53M Buy
473,509
+16,700
+4% +$292K 0.04% 407
2024
Q2
$7.42M Sell
456,809
-218,705
-32% -$3.37M 0.03% 419
2024
Q1
$9.53M Buy
675,514
+8,100
+1% +$102K 0.03% 484
2023
Q4
$6.97M Hold
667,414
0.02% 557
2023
Q3
$6.81M Hold
667,414
0.02% 536
2023
Q2
$5.03M Hold
667,414
0.02% 660
2023
Q1
$5.91M Hold
667,414
0.02% 601
2022
Q4
$6.09M Buy
667,414
+11,000
+2% +$96K 0.02% 576
2022
Q3
$5.3M Hold
656,414
0.02% 606
2022
Q2
$4.94M Buy
656,414
+11,000
+2% +$95.8K 0.02% 635
2022
Q1
$6.06M Buy
645,414
+55,900
+9% +$467K 0.02% 632
2021
Q4
$4.72M Buy
589,514
+13,300
+2% +$120K 0.01% 775
2021
Q3
$5.61M Sell
576,214
-90,600
-14% -$848K 0.02% 686
2021
Q2
$6.6M Hold
666,814
0.02% 638
2021
Q1
$7.7M Buy
666,814
+9,300
+1% +$107K 0.03% 565
2020
Q4
$6.34M Hold
657,514
0.02% 629
2020
Q3
$5.92M Hold
657,514
0.02% 594
2020
Q2
$8.11M Buy
657,514
+9,900
+2% +$112K 0.03% 462
2020
Q1
$5.82M Hold
647,614
0.03% 532
2019
Q4
$6.35M Hold
647,614
0.02% 632
2019
Q3
$4.46M Hold
647,614
0.02% 835
2019
Q2
$5.98M Buy
647,614
+207,614
+47% +$2.5M 0.02% 548
2019
Q1
$6.9M Hold
440,000
0.03% 509
2018
Q4
$6.79M Hold
440,000
0.03% 472
2018
Q3
$9.48M Hold
440,000
0.03% 442
2018
Q2
$10.7M Hold
440,000
0.04% 408
2018
Q1
$7.52M Hold
440,000
0.03% 480
2017
Q4
$8.34M Sell
440,000
-137,900
-24% -$2.07M 0.03% 460
2017
Q3
$10.2M Hold
577,900
0.04% 421
2017
Q2
$19.2M Hold
577,900
0.08% 281
2017
Q1
$18.5M Hold
577,900
0.08% 275
2016
Q4
$20.9M Buy
577,900
+61,100
+12% +$2.44M 0.09% 254
2016
Q3
$23.8M Sell
516,800
-108,300
-17% -$5.65M 0.1% 232
2016
Q2
$31.4M Hold
625,100
0.14% 171
2016
Q1
$33.4M Buy
625,100
+66,200
+12% +$3.88M 0.15% 159
2015
Q4
$36.7M Buy
558,900
+58,600
+12% +$3.62M 0.15% 158
2015
Q3
$28.2M Hold
500,300
0.12% 202
2015
Q2
$29.6M Hold
500,300
0.11% 212
2015
Q1
$31.2M Hold
500,300
0.12% 201
2014
Q4
$28.8M Hold
500,300
0.11% 212
2014
Q3
$26.9M Sell
500,300
-108,000
-18% -$5.72M 0.11% 223
2014
Q2
$31.9M Hold
608,300
0.13% 192
2014
Q1
$32.1M Hold
608,300
1.01% 12
2013
Q4
$24.4M Sell
608,300
-85,500
-12% -$3.37M 0.68% 16
2013
Q3
$26.2M Buy
693,800
+413,300
+147% +$16.1M 0.8% 14
2013
Q2
$11M Buy
+280,500
New +$10.9M 0.35% 30

Other funds holding TEVA

State of New Jersey Common Pension Fund D's TEVA Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Teva Pharmaceuticals (TEVA) stake by 2.5% in Q2 2026, selling an estimated $430K and leaving 511,409 shares worth $17.3M. The position accounts for 0.06% of the portfolio, ranked #266.

State of New Jersey Common Pension Fund D first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.7M in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 511,409 shares of Teva Pharmaceuticals worth $17.3M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 12,900 Teva Pharmaceuticals shares in Q2 2026, an estimated $430K.
  • Teva Pharmaceuticals made up 0.06% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #266 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • State of New Jersey Common Pension Fund D's Teva Pharmaceuticals position peaked at $36.7M in Q4 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.